Preliminary results from digestive adaptation: A new surgical proposal for treating obesity, based on physiology and evolution

Sao Paulo Medical Journal

Volumn 124, Issue 4, 2006, Pages 192-197

  Santoro, Sérgio ^a,d   Velhote, Manoel Carlos Prieto ^b   Malzoni, Carlos Eduardo ^a   Milleo, Fábio Quirino ^c   Klajner, Sidney ^a   Campos, Fábio Guilherme ^b  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Hospital Vicentino da Sociedade Beneficente São Camilo   (Brazil)

^d Faculdade de Medicina da Universidade de São Paulo ^*  (Brazil)

Author keywords

Ghrelin; Glucagon like peptide 1; Morbid obesity; Peptide YY; Surgery

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; CEFAZOLIN; GHRELIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN;

ABDOMINAL BLEEDING; ADULT; AGED; ARTICLE; BARIATRIC SURGERY; BODY MASS; CALORIC INTAKE; CASE STUDY; COMORBIDITY; CONSTIPATION; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DIGESTIVE FUNCTION; DYSPEPSIA; FEMALE; FOLLOW UP; GASTROINTESTINAL SURGERY; GASTROINTESTINAL TRACT; HUMAN; INTESTINE RESECTION; LACERATION; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NUTRIENT CONCENTRATION; NUTRITIONAL SUPPORT; OMENTECTOMY; OPERATION DURATION; OUTCOME ASSESSMENT; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PROTEIN SYNTHESIS; SATIETY; SPLEEN ABSCESS; STOMACH FISTULA; SURGICAL MORTALITY; UMBILICAL HERNIA; VERTICAL GASTRECTOMY; WEIGHT REDUCTION;

EID: 33750570741     PISSN: 15163180     EISSN: 15163180     Source Type: Journal    
DOI: 10.1590/s1516-31802006000400004     Document Type: Article

References (42)

1. Byrne TK. Complications of surgery for obesity. Surg Clin North Am. 2001;81(5):1181-93, vii-viii.
2. Favretti F, Cadiere GB, Segato G, et al. Laparoscopic adjustable silicone gastric banding (Lap-Band): how to avoid complications. Obes Surg. 1997;7(4):352-8.
3. Castillo J, Fábrega E, Escalante CF, et al. Liver transplantation in a case of steatohepatitis and subacute hepatic failure after biliopancreatic diversion for morbid obesity. Obes Surg. 2001;11(5):640-2.
4. Cotler SJ, Vitello JM, Guzman G, Testa G, Benedetti E, Layden TJ.. Hepatic decompensation after gastric bypass surgery for severe obesity. Dig Dis Sci. 2004;49(10):1563-68.
5. Kreymann B, Williams, G, Ghatei MA, Bloom SR. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet. 1987;2(8571):1300-4.
6. Nauck MA. Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest. 1993;91(1):301-7.
7. Creutzfeldt WO, Kleine N, Willms, B. Orskov C. Holst JJ, Nauck MA. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide, I(7-36) amide in type I diabetic patients. Diabetes Care. 1996;19(6):580-6.
8. Layer P, Holst JJ, Grandt D, Goebell H. Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humnas. Dig Dis Sci. 1995:40(5):1074-82.
9. Nauck MA, Niedereichholz U, Ettler R, et al. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol. 1997;273(5 Pt 1):E981-8.
10. Schirra J, Wank U, Arnold R, Goke B, Katschinski M. Effects of glucagon-like peptide-1(7-36)amide on motility and sensation of the proximal stomach in humans. Gut. 2002;50(3):341-8.
11. Kastin AJ, Akerstrom V, Pan W. Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier. J Mol Neurosci. 2002;18(1-2):7-14.
12. Muccioli G, Tschop M, Papotti M, Deghenghi R, Heiman M, Ghigo E. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol. 2002;440(2-3):235-54.
13. Penalva A. Baldelli R, Camina JP, et al. Physiology and possible pathology of growth hormone secretagogues. J Pediatr Endocrinol Metab. 2001;14(Suppl 5):1207-12; discussion 1261-2.
14. Pinkney J, Williams G. Ghrelin gets hungry. Lancet. 2002;359(9315):1360-1.
15. Lustig RH. The neuroendocrinolgy of obesity. Endocrinol Metab Clin North Am. 2001;30(3):765-85.
16. Cummings DE, Weigle DS, Frayo, RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346(21):1623-30.
17. Juhan-Vague I, Alessi MC, Morange PE. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity. Ann Med. 2000;32(Suppl 1):78-84.
18. van Hinsbergh VW, Kooistra T, Scheffer MA, Hajo van Bockel J, van Muijen GN. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood. 1990;75(7):1490-7.
19. Juhan-Vague I, Alessi MC. PAI-1, obesity, insulin resistance and risk of cardiovascular events. Thromb Haemost. 1997;78(1):656-60.
20. Carmichael AR, Tate G, King RF, Sue-Ling HM, Johnston D. Effects of the Magenstrasse and Mill operation for obesity on plasma plasminogen activator inhibitor type 1, tissue plasminogen activator, fibrinogen and insulin. Pathophysiol Haemost Thromb. 2002;32(1):40-3.
21. Thorne A, Lonnqvist F, Apelman J, Hellers G, Arner P. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord. 2002;26(2):193-9.
22. McTernan PC, McTernan CL, Chetry R, et al. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab. 2002;87(5):2407.
23. McTernan CL, McTernan PG, Harte AL. Levick PL, Barnett AH, Kumar S. Resistin, central obesity, and type 2 diabetes. Lancet. 2002;359(9300):46-7.
24. Bergman RN, Van Citters GW, Mittelman SD, et al. Central role of the adipocyte in the metabolic syndrome. J Investig Med. 2001;49(1):119-26.
25. Batterham RL, Bloom SR. The gut hormone peptide YY regulates appetite. Ann N Y Acad Sci. 2003;994:162-8.
26. Cohen MA, Ellis SM, Le Roux CW, et al. Oxyntomodulin suppresses appetite and reducts food intake in humans. J Clin Endocrinol Metab. 2003;88(10):4696-701.
27. van den Hoek AM, Heijboer AC, Corssmit EP, et al. PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet. Diabetes. 2004;53(8):1949-52.
28. Stevens CE, Hume ID. Comparative Physiology of the Vertebrate Digestive System. 2nd ed. Cambridge: Cambridge University Press; 1995.
29. Milton K. A hypothesis to explain the role of meat-eating in human evolution. Evolutionary Anthropology. 1999;8(1):11-21.
30. Milton K. Primate diets and gut morphology: implications for hominid evolution. In: Harris M. Ross EB. editors. Food and evolution: toward a theory of human food habits. Philadelphia: Temple University Press; 1987. p. 93-115.
31. Aiello LC, Wheeler P. The expensive tissue hypothesis: The brain and the digestive system in human and primate evolution. Cur Anthropol. 1995;36:199-221.
32. Leonard WR, Robertson ML. Evolutionary perspectives on human nutrition: the influence of brain and body size on diet and metabolism. Am J Hum Biol. 1994;6:77-88.
33. Lugari R, Dei Cas A. Ugolotti D, et al. Evidence for early impairment of glucagon-like peptide 1-induced insulin secretion in human type 2 (non insulin-dependent) diabetes. Horm Metab Res. 2002;34(3):150-4.
34. Ranganath LR, Beety JM, Morgan LM, Wright JW, Howland R, Marks V. Attenuated GLP-1 secretion in obesity: cause or consequence? Gut. 1996;38(6):916-9.
35. Hounnou G, Destrieux C, Desme J, Bertrand P, Velut S. Anatomical study of the length of the human intestine. Surg Radiol Anat. 2002;24(5):290-4.
36. Santoro S, Velhote MCP, Mechenas ASG, Malzoni CE, Strassmann V. Gastro-omentectomia Laparoscópica Adaptative: Novo Procedimento para Tratamento e Prevenção do Avanço da Obesidade - Bases Fisiológicas e Evolucionárias. [Laparoscopic adaptive gastro-omentectomy as an early procedure to treat and prevent the progress of obesity - evolutionary and physiological support]. Revista Brasileira de Videocirurgia. 2003;1(3):96-102.
37. Santoro S. Relações entre o comprimento do intestino e a obesidade: Hipótese: a síndrome do intestino longo. Einstein. 2003;1:44-46. Available from: http://www.einstein.br.biblioteca/pdf/On%20line%2030.pdf. Accessed in 2006 (Jul 5).
38. Santoro S, Velhote MCP, Malzoni CE, Mechenas ASG, Strassmann V, Scheinberg. Adaptação digestive: uma nova proposta cirúrgica para tartar a obesidade com base em fisiologia e evolução. [Digestive adaptation: a new surgical proposal to treat obesity based in physiology and evolution]. Einstein. 2003; 1(2):99-104. Available from: http://www.einstein.br/biblioteca/artigos/ adaptação%20digestiva%20traduzido.pdf. Accessed in 2006 (Jul 5).
39. Baltasar A, Bou R, Bengochea M, et al. Duodenal switch: an effective therapy for morbid obesity - intermediate results. Obes Surg. 2001;11(1):54-8.
40. Adkins Jr RB, Davies J. Gross and microscopic anatomy of the stomach and small intestine. In: Scott Jr HW, Sawyers JL, editors. Surgery of the stomach, duodenum and small bowel. Boston: Blackwell Scientitic Publications; 1987. p. 45-60
41. Gardner E. O abdomen. Estudo regional do corpo humano. In: Gardner E, Gray DS, Rahylly R, editors. Anatomia. Rio de Janeiro: Guanabara Koogan; 1967. p. 407-84.
42. Santoro S, Velhote MCP, Malzoni CE, Mechenas ASG, Damiani D, Maksoud JG. Adaptação digestive com reserve intestinal: nova proposta cirúrgica para obesidade mórbida. [Digestive adaptation with intestinal reserve: a new surgical proposal for morbid obesity]. Revista Brasileira de Videocirurgia. 2004;2(3):130-8.